EEF1A1.md
... ...
@@ -30,13 +30,8 @@ timeline
30 30
31 31
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
32 32
33
-|Entity|source |frequency (%)|
34
-|:------:|:--------------:|:-------------:|
35
-|DLBCL |GAMBL genomes | 4.78 |
36
-|DLBCL |Schmitz cohort| 2.98 |
37
-|DLBCL |Reddy cohort | 2.50 |
38
-|DLBCL |Chapuy cohort | 4.70 |
39
-|FL |GAMBL genomes |11.32 |
33
+[[include:DLBCL_EEF1A1.md]]
34
+[[include:FL_EEF1A1.md]]
40 35
41 36
## Mutation pattern and selective pressure estimates
42 37
EP300.md
... ...
@@ -31,21 +31,13 @@ timeline
31 31
|Entity|Tier|Description |
32 32
|:------:|:----:|--------------------------------------|
33 33
|![MZL](images/icons/MZL_tier1.png)|1|high-confidence MZL gene[@rossiCodingGenomeSplenic2012]|
34
-|![DLBCL](images/icons/DLBCL_tier1.png) |1-EE |high-confidence DLBCL gene supported by functional data [@pasqualucciInactivatingMutationsAcetyltransferase2011]|
35
-|![FL](images/icons/FL_tier1.png) |1-EE |high-confidence FL gene supported by functional data [@pasqualucciInactivatingMutationsAcetyltransferase2011]|
34
+|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene supported by functional data [@pasqualucciInactivatingMutationsAcetyltransferase2011]|
35
+|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene supported by functional data [@pasqualucciInactivatingMutationsAcetyltransferase2011]|
36 36
37 37
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
38 38
39
-|Entity|source |frequency (%)|
40
-|:------:|:---------------------:|:-------------:|
41
-|BL |GAMBL genomes+capture| 4.62 |
42
-|BL |Thomas cohort | 4.20 |
43
-|BL |Panea cohort | 7.90 |
44
-|DLBCL |GAMBL genomes |11.85 |
45
-|DLBCL |Schmitz cohort | 9.79 |
46
-|DLBCL |Reddy cohort | 7.11 |
47
-|DLBCL |Chapuy cohort | 8.12 |
48
-|FL |GAMBL genomes |12.47 |
39
+[[include:DLBCL_EP300.md]]
40
+[[include:FL_EP300.md]]
49 41
50 42
## Mutation pattern and selective pressure estimates
51 43
ETS1.md
... ...
@@ -38,15 +38,8 @@ timeline
38 38
39 39
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
40 40
41
-|Entity|source |frequency (%)|
42
-|:------:|:---------------------:|:-------------:|
43
-|DLBCL |GAMBL genomes | 4.59 |
44
-|DLBCL |Schmitz cohort | 7.87 |
45
-|DLBCL |Reddy cohort | 4.40 |
46
-|DLBCL |Chapuy cohort | 5.56 |
47
-|BL |GAMBL genomes+capture| 7.62 |
48
-|BL |Thomas cohort | 7.60 |
49
-|BL |Panea cohort |11.90 |
41
+[[include:DLBCL_ETS1.md]]
42
+[[include:FL_ETS1.md]]
50 43
51 44
## Mutation pattern and selective pressure estimates
52 45
ETV6.md
... ...
@@ -34,12 +34,7 @@ timeline
34 34
35 35
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
36 36
37
-|Entity|source |frequency (%)|
38
-|:------:|:--------------:|:-------------:|
39
-|DLBCL |GAMBL genomes | 4.97 |
40
-|DLBCL |Schmitz cohort|10.43 |
41
-|DLBCL |Reddy cohort | 5.81 |
42
-|DLBCL |Chapuy cohort |10.26 |
37
+[[include:DLBCL_ETV6.md]]
43 38
44 39
## Mutation pattern and selective pressure estimates
45 40
EZH2.md
... ...
@@ -44,16 +44,9 @@ timeline
44 44
45 45
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
46 46
47
-|Entity|source |frequency (%)|
48
-|:------:|:---------------------:|:-------------:|
49
-|BL |GAMBL genomes+capture| 3.46 |
50
-|BL |Thomas cohort | 1.30 |
51
-|BL |Panea cohort |10.90 |
52
-|DLBCL |GAMBL genomes |13.77 |
53
-|DLBCL |Schmitz cohort | 9.15 |
54
-|DLBCL |Reddy cohort | 8.91 |
55
-|DLBCL |Chapuy cohort | 5.56 |
56
-|FL |GAMBL genomes |24.94 |
47
+
48
+[[include:DLBCL_EZH2.md]]
49
+[[include:FL_EZH2.md]]
57 50
58 51
## Mutation pattern and selective pressure estimates
59 52